Overview
Edward Taylor practices practicing medicine in Lincoln, United Kingdom.
His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA) and Streptococcal Group A Infection.
He is actively involved in clinical research, co-authoring 16 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Edward J. Taylor
Is Edward J. Taylor a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?
MediFind is an objective health platform that identifies experts based on real-world data. Edward J. Taylor is classified as an Experienced expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Edward J. Taylor participate in research or clinical trials?
Yes. Edward J. Taylor has published 16 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Edward J. Taylor's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- Streptococcal Group A InfectionMr. Taylor isExperienced. Learn about Streptococcal Group A Infection.